CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $136,261 | -30.2% | 2,515 | -9.6% | 0.00% | – |
Q1 2024 | $195,114 | -64.4% | 2,783 | -57.6% | 0.00% | -100.0% |
Q4 2023 | $547,559 | +168.1% | 6,559 | -5.4% | 0.00% | – |
Q3 2023 | $204,256 | +10.8% | 6,935 | +27.0% | 0.00% | – |
Q2 2023 | $184,264 | +1.2% | 5,461 | +5.3% | 0.00% | – |
Q1 2023 | $182,110 | -24.6% | 5,187 | -1.9% | 0.00% | – |
Q4 2022 | $241,558 | -48.3% | 5,286 | -45.1% | 0.00% | -100.0% |
Q3 2022 | $467,000 | -52.9% | 9,633 | -61.8% | 0.00% | -50.0% |
Q2 2022 | $992,000 | +544.2% | 25,186 | +324.7% | 0.00% | – |
Q1 2022 | $154,000 | -34.5% | 5,930 | +14.9% | 0.00% | – |
Q4 2021 | $235,000 | +55.6% | 5,163 | +23.4% | 0.00% | – |
Q3 2021 | $151,000 | +81.9% | 4,184 | +2.1% | 0.00% | – |
Q2 2021 | $83,000 | -9.8% | 4,097 | +5.0% | 0.00% | – |
Q1 2021 | $92,000 | +67.3% | 3,901 | +43.2% | 0.00% | – |
Q4 2020 | $55,000 | +66.7% | 2,725 | +97.0% | 0.00% | – |
Q3 2020 | $33,000 | 0.0% | 1,383 | 0.0% | 0.00% | – |
Q2 2020 | $33,000 | +83.3% | 1,383 | -7.1% | 0.00% | – |
Q1 2020 | $18,000 | – | 1,489 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |